ARTICLE | Company News
Genzyme General, Transkaryotic autoimmune/inflammation news
July 31, 2000 7:00 AM UTC
GENZ filed suit against TKTX in the U.S. District Court for the District of Delaware claiming that TKTX's Replagal agalsidase alfa enzyme replacement therapy for Fabry disease infringes GENZ's U.S. p...